Paradigm Genetics is the first company to qualify for Agilent Technologies' certified microarray service provider programme
Paradigm Genetics, a biotechnology company, and Agilent Technologies have announced that Paradigm is the first company to be certified under Agilent's new certified microarray service provider programme.
The certification validates Paradigm's ability to provide high-quality microarray processing and data analysis services using Agilent microarrays and expands on the long-standing relationship between the two companies.
Since launching its microarray services business in February 2003, Paradigm has offered research services, using Agilent custom and catalogue microarrays, to biotechnology, pharmaceutical and agrochemical companies.
Earlier, the company was awarded a $32.2 million contract with the National Institutes of Environmental Health Sciences based in part on their demonstrated expertise in using the Agilent technology platform. Certification for the Agilent programme is granted once laboratory personnel complete a training programme and the laboratory, as a whole, passes a rigorous set of assessments.
To be eligible, a service laboratory must analyse Agilent 60-mer microarrays on the complete Agilent gene expression platform, which consists of a microarray scanner, hybridisation and labelling kits, feature extraction software, and one of the Rosetta gene expression data analysis systems.
By using this complete platform, laboratories maximise the quality, reproducibility and reliability of results obtained from Agilent microarrays.
"This certification constitutes a formal endorsement from Agilent that we can and continue to provide reliable microarray results that researchers can count on from sample to sample, study to study," said Heinrich Gugger, president and CEO of Paradigm.
"We offer the highest quality microarray service to a research community eager to make use of Agilent's highly sensitive 60-mer oligonucleotide format".
"By becoming an Agilent Certified Services Provider, Paradigm ensures optimal operation of Agilent microarrays, and provides customers with added confidence in the quality of its service," said Barney Saunders, vice president and general manager of Agilent's Bio-Research Solutions.
"As a longtime provider of quality research services using Agilent microarrays, Paradigm was a natural partner with whom to initiate this programme."
